T
TNGX
Tango Therapeutics Inc
24.06
+2.50+11.60%After Hours: 24.19 +0.13 +0.54%19:55 04/14 EDT
OPEN/PREV CLOSE21.85/21.56
TODAY RANGE21.58-24.08
VOL3.54M
MARKET CAP3.43B
52 WEEK RANGE1.030-24.08
AVG VOL (3M)3.29M
% TURNOVER2.48%
TURNOVER--
P/E (TTM)-27.5097
% RANGE11.60%
EPS(TTM)-0.8746
P/E(FORWARD)-18.7969
P/B9.45
BVPS2.547
DIVIDEND--
P/S52.43
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.37B
SHARES OUTSTANDING142.69M
NEXT EARNINGS05/11-05/15
FREE FLOAT140.01M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·18h ago
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
Seeking Alpha·04/07 15:05
Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Seeking Alpha·04/06 13:35
Most and least shorted stocks over $2B market cap
Seeking Alpha·04/03 12:00
Most and least shorted mid-to mega-cap healthcare stocks in March
Seeking Alpha·04/02 18:29
Tango a new Buy at Canaccord Genuity on 2026 catalysts
Dow Jones·04/02 14:19
Tango Therapeutics Price Target Announced at $30.00/Share by Canaccord Genuity
TipRanks·04/02 12:01
Canaccord starts Tango Therapeutics with Buy on PRMT5 inhibitor
TipRanks·04/02 09:15
Tango Therapeutics initiated with a Buy at Canaccord
Seeking Alpha·03/30 18:10
Tango Therapeutics is the best performing healthcare stock in March
Same Industry
Name/Symbol
Change%
Price